News round-up for 8 – 12 December by Bruno Quinney, Content Team at DDW.
This week in DDW, innovative treatments have been developed for neurodegenerative diseases, allergies and arthritis. Elsewhere, China is becoming the dominant force in the biotech sector.
The top stories:
Once-a-day pill could reverse cognitive decline, trial shows
Tazbentetol demonstrated rapid, sustained cognitive improvement in a Phase IIa trial. The randomised, double-blind, placebo-controlled…
